Similarly, in laryngeal cancer cells TU212 and TU686, stable transfectants with high CTSL expression exhibited an increase in IL6‐JAK‐STAT3 pathway activity, while low expression stable transfectants showed a decrease (Figure 5G–J). This evidence concerns the gene STAT3 and laryngeal carcinoma.